U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497503) titled 'A Study of B-3E07 and Forsteo(R) in Healthy Adult Female Participants' on March 23.
Brief Summary: The main aim of the study is to evaluate the pharmacokinetic (PK) biosimilarity of B-3E07 and European Union (EU) - sourced Forsteo(R) in healthy adult female participants.
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
BIOLOGICAL: Forsteo(R)
Forsteo(R) will be administered as SC injection.
BIOLOGICAL: B-3E07
B-3E07 will be administered as SC injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Syneos Health
Disclaimer: Curated by HT Syndication....